FDA Inspection 1040552 — Siegfried Pharma AG
The FDA completed an inspection of Siegfried Pharma AG on December 8, 2017 in Zofingen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zofingen (Switzerland)